| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |